HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiteru Katsura Selected Research

Carcinoma (Carcinomatosis)

1/2023[A Case of Multiple Postoperative Recurrence of Hepatocellular Carcinoma Successfully Treated with Atezolizumab plus Bevacizumab].
12/2019[A Case of Liver Metastases of Ampullary Carcinoma with Clinical Complete Response Treated with Gemcitabine plus Cisplatin].
11/2013[Pathological complete response in advanced gastric carcinoma with lymph node metastasis treated with combination neoadjuvant chemotherapy comprising S-1 and cisplatin-a case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiteru Katsura Research Topics

Disease

53Neoplasms (Cancer)
01/2024 - 11/2010
32Neoplasm Metastasis (Metastasis)
04/2023 - 11/2014
18Stomach Neoplasms (Stomach Cancer)
12/2023 - 11/2015
12Breast Neoplasms (Breast Cancer)
03/2022 - 11/2014
10Colorectal Neoplasms (Colorectal Cancer)
02/2023 - 11/2014
10Hepatocellular Carcinoma (Hepatoma)
01/2023 - 11/2011
10Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 11/2013
9Adenocarcinoma
12/2021 - 11/2013
7Rectal Neoplasms (Rectal Cancer)
02/2023 - 01/2018
7Lymphatic Metastasis
12/2021 - 11/2013
5Pathologic Constriction (Stenosis)
12/2022 - 11/2014
5Hemorrhage
12/2022 - 11/2014
4Sigmoid Neoplasms
12/2022 - 11/2015
3Carcinoma (Carcinomatosis)
01/2023 - 11/2013
3Cholangitis
12/2021 - 11/2013
3Infections
03/2019 - 11/2015
3Disease Progression
12/2018 - 11/2013
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2018 - 02/2018
3Abscess
11/2017 - 11/2015
3Colonic Neoplasms (Colon Cancer)
11/2017 - 11/2014
2Choledocholithiasis
04/2024 - 08/2021
2Pathologic Complete Response
12/2023 - 04/2020
2Biliary Tract Neoplasms (Biliary Tract Cancer)
02/2023 - 12/2018
2Wounds and Injuries (Trauma)
01/2022 - 12/2020
2Surgical Wound Infection
01/2022 - 11/2017
2Gallbladder Neoplasms (Gallbladder Cancer)
12/2021 - 08/2021
2Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
12/2021 - 01/2018
2Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2021 - 11/2017
2Carcinoid Tumor (Carcinoid)
02/2021 - 11/2015
2Enteritis
12/2020 - 11/2017
2Intestinal Volvulus (Volvulus)
12/2020 - 12/2016
2Neutropenia
01/2020 - 12/2018
2Obstructive Jaundice (Cholestatic Jaundice)
12/2019 - 11/2014
2Fibrosis (Cirrhosis)
03/2019 - 11/2014
2Fever (Fevers)
12/2018 - 02/2018
2Esophageal Neoplasms (Esophageal Cancer)
12/2018 - 12/2018
2Liver Failure
11/2017 - 11/2016
2Diarrhea
11/2015 - 11/2013
1Cholecystolithiasis
04/2024
1Bile Duct Neoplasms (Bile Duct Cancer)
12/2023
1Pancreatic Fistula (Pancreatic Fistulas)
12/2023
1Klatskin Tumor
12/2023
1Hernia (Hernias)
04/2023
1Cecal Neoplasms
04/2023
1Margins of Excision
02/2023

Drug/Important Bio-Agent (IBA)

12Cisplatin (Platino)FDA LinkGeneric
03/2023 - 11/2013
7GemcitabineFDA Link
02/2023 - 11/2013
6Estrogen ReceptorsIBA
12/2019 - 11/2014
6Progesterone Receptors (Progesterone Receptor)IBA
12/2019 - 11/2014
5Trastuzumab (Herceptin)FDA Link
03/2023 - 11/2015
5Bevacizumab (Avastin)FDA Link
01/2023 - 11/2017
5Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 11/2011
4Capecitabine (Xeloda)FDA Link
03/2023 - 11/2016
4Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 12/2013
3pembrolizumabIBA
12/2023 - 12/2021
3Hormones (Hormone)IBA
03/2021 - 11/2014
3130-nm albumin-bound paclitaxelIBA
03/2020 - 11/2015
3human ERBB2 proteinIBA
11/2014 - 11/2014
2Immune Checkpoint InhibitorsIBA
12/2023 - 12/2021
2atezolizumabIBA
01/2023 - 12/2021
2Imatinib Mesylate (Gleevec)FDA Link
12/2022 - 11/2014
2Paclitaxel (Taxol)FDA LinkGeneric
03/2020 - 11/2016
2Sorafenib (BAY 43-9006)FDA Link
03/2019 - 12/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
02/2018 - 11/2016
2Phosphotransferases (Kinase)IBA
01/2018 - 11/2014
2folfirinoxIBA
11/2017 - 11/2015
2Cetuximab (Erbitux)FDA Link
11/2017 - 11/2014
2titanium silicide (TS-1)IBA
11/2016 - 11/2015
1tetra-4-amidinophenoxypropane (TAPP)IBA
04/2023

Therapy/Procedure

36Drug Therapy (Chemotherapy)
03/2023 - 11/2014
31Therapeutics
12/2023 - 11/2011
16Lymph Node Excision (Lymph Node Dissection)
12/2022 - 11/2014
12Gastrectomy
12/2023 - 11/2015
9Hepatectomy
12/2023 - 11/2010
7Colectomy
02/2023 - 11/2014
7Stents
12/2022 - 11/2014
6Pancreatectomy
03/2021 - 11/2015
5Chemoradiotherapy
12/2023 - 11/2015
5Laparotomy
12/2022 - 12/2016
5Neoadjuvant Therapy
12/2022 - 11/2013
5Segmental Mastectomy (Lumpectomy)
03/2022 - 11/2014
5Mastectomy (Mammectomy)
12/2021 - 11/2014
4Cholecystectomy
04/2024 - 11/2015
4Length of Stay
01/2024 - 11/2015
4Proctectomy
02/2023 - 11/2016
3Operative Surgical Procedures
02/2023 - 12/2016
3Colostomy
02/2023 - 11/2017
3Radiotherapy
03/2022 - 04/2019
3Adjuvant Chemotherapy
12/2021 - 11/2017
3Pancreaticoduodenectomy
12/2020 - 11/2014
2Laparoscopic Cholecystectomy
12/2021 - 08/2021
2Combined Modality Therapy
12/2021 - 11/2014
2Palliative Care (Palliative Therapy)
03/2021 - 11/2014
2Catheters
02/2021 - 12/2016
2Combination Drug Therapy (Combination Chemotherapy)
12/2019 - 11/2015
2Induction Chemotherapy
11/2017 - 05/2015
2Splenectomy
11/2017 - 11/2015
1Choledochostomy
04/2024
1Minimally Invasive Surgical Procedures
01/2024